CN Patent

CN110627812B — 作为trk抑制剂的杂环化合物

Assigned to Beijing Innocare Pharma Tech Co Ltd · Expires 2022-10-11 · 4y expired

What this patent protects

Patent listed against larotrectinib-sulfate.

Drugs covered by this patent

Patent Metadata

Patent number
CN110627812B
Jurisdiction
CN
Classification
—
Expires
2022-10-11
Drug substance claim
No
Drug product claim
No
Assignee
Beijing Innocare Pharma Tech Co Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.